Cresp 100mcg Injection is a medication containing Darbepoetin alfa, a synthetic form of erythropoietin. It functions by stimulating the bone marrow to produce more red blood cells, which are essential for carrying oxygen throughout the body. This increased red blood cell count helps to combat anemia, a condition characterized by a deficiency of red blood cells or hemoglobin.
Cresp 100mcg Injection is primarily indicated for the treatment of anemia associated with chronic kidney disease (CKD) in both dialysis-dependent and non-dialysis-dependent patients. It is also used to treat chemotherapy-induced anemia in patients with non-myeloid malignancies. The dosage and administration of Cresp 100mcg Injection should be determined by a healthcare professional based on the individual patient’s condition and response. It is typically administered subcutaneously or intravenously.
Common side effects may include headache, nausea, vomiting, diarrhea, and hypertension. Serious side effects, though less common, can involve blood clots, allergic reactions, and an increased risk of tumor progression. Patients should report any unusual symptoms to their doctor immediately. Cresp 100mcg Injection should be stored at room temperature, protected from light, and kept out of reach of children.
